Rogue proteins not intended from spike mRNA are candidates for molecular mimicry. The novel mRNA vaccine technology given emergency use authorization is now known to be fraught with risks – some of which were foretold before the production of specific mRNA injectables. These vaccines, which include those developed by Moderna and Pfizer-BioNTech, are supposed to […]
